Research Progress on the Drug Resistance Mechanism of Acute Myeloid Leukemia Mediated by the MicroRNA -Review.
10.7534/j.issn.1009-2137.2017.01.046
- Author:
Ying-Dan HUANG
1
;
Quan-Yi LU
2
Author Information
1. Department of Hematology, Zhongshan Hospital of Xiamen University, Key Clinical Department of Xiamen City, Xiamen 361004, Fujian Province, China.
2. Department of Hematology, Zhongshan Hospital of Xiamen University, Key Clinical Department of Xiamen City, Xiamen 361004, Fujian Province, China. E-mail: luquanyi@xmu.edu.cn.
- Publication Type:Journal Article
- From:
Journal of Experimental Hematology
2017;25(1):255-258
- CountryChina
- Language:Chinese
-
Abstract:
The acute myeloid leukemia is a very common malignant tumor of hematopoietic system, which is seriously harmful to human health. The long-term survival rate of routine chemotherapy is not satisfactory, especially in the high risk patients. Resistance to chemotherapy drugs is one of the major reasons, which causes the refractorines and relapse of the acute myeloid leukemia. The microRNA found in eukaryote is an endogenous non-coding micromolecular signle-stranded RNA of 19 to 25 nt. The miRNA can degrade the specific RNA or inhibit its translation through combining to 3' untranslated regions of the specific RNA, which contributes to regulate the expression of the target gene. There are already some evidences showing that the disorder of miRNA plays an important role in the genesis and progress of the tumors. Recently, more and more researches suggest that the miRNA is also important in the genesis of drug resistance to tumors. This review summarizes the research progress and the major mechanism of drug-resistance mediated by the miRNA in AML, including multiple drug resistance, cell cycle and the tolerance to apoptosis, all of which are associated with ABC transport protein.
